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of pneumonectomy, occurring in 2% to 16% of cases.1,2
Although more uncommon, it may complicate any kind
of pulmonary resection.3 It is a life-threatening condi-
tion with a mortality of approximately 40% in post-
pneumonectomy empyema.1-3 Empyema is frequently
associated with a bronchopleural fistula (BPF) involv-
ing the stump of the main bronchus or of a lobar or a
segmental bronchus; air leaks may originate also from
more peripheral bronchi, as well as from bronchoalveo-
lar fistulas.3 The presence of a BPF obviously increases
the morbidity and the mortality of empyema by provid-
ing a source of continuous contamination of the pleural
space and promoting aspiration of infected pleural fluid
in the remaining lung.1,4 Therefore, the optimal treat-
ment of empyema complicating pulmonary resections
M anagement of empyema complicating pulmonaryresections still represents a challenge in thoracic
surgery. Empyema is not uncommon as a complication
Objective: Successful treatment of postoperative empyema remains a chal-
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pneumonectomy (n = 30), bilobectomy (n = 5), lobectomy (n = 9), and
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intrathoracic flap transposition was eventually performed. Muscular (n =
29), omental (n = 5), or combined muscular and omental (n = 2) flaps were
used to obliterate the thoracostomy cavity and to close a possibly associated
bronchopleural fistula. In 9 patients with postpneumonectomy cavities too
wide to be filled by the available flaps, a limited thoracoplasty represented
an intermediate step.
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ies, with the aim of correctly draining all purulent collection.
Care was taken to limit the injury to chest wall muscles. Two
to four rib segments (generally not more than 10 cm long)
were resected to widely expose the empyema cavity. The skin
was advanced and brought down to the parietal pleura. Pus
and necrotic debris were gently removed, and the cavity was
filled with povidone iodine–soaked gauze. The dressings
were initially changed once daily and, after discharge, every
2 days. Mean hospital stay after OWT was 8 days.
Elimination of gangrenous material and reduction of the
pleural cavity were achieved in all the cases; in 21 of 39
patients, spontaneous closure of BPF occurred (Table II).
In 10 (8 men and 2 women; mean age, 63.5 years; age
range, 42-77 years) of 46 patients, OWT was definitive, and
the second step of the treatment (myoplasty or omentopexy)
was never performed because of patient death, concomitant
major illness, locoregional or metastatic tumor recurrence,
spontaneous closure, or patient choice. Thirty-six patients (32
men and 4 women; mean age, 61.2 years; age range, 37-79
years) underwent eventual intrathoracic muscular or omental
transposition (Table I).
Flap transposition. The OWT was not closed by the sec-
ond step of the Clagett procedure (ie, obliteration of the
pleural cavity with an antibiotic solution and skin closure by
direct approximation of edges).10 In the presence of a BPF,
such an approach is not feasible; furthermore, in the absence
of a BPF, the risk of empyema recurrence is high.7 We pre-
ferred to use intrathoracic flap transposition to close the
OWT. It was considered possible if no sign of suppuration
existed and abundant granulation tissue was present. The
presence of a persistent BPF (as observed in 14/36 cases) did
not represent a contraindication for closure. Satisfactory clin-
ical conditions and, for patients previously operated on for
lung cancer, no evidence of tumor recurrence at restaging
were also mandatory. The timing of closure was also influ-
enced by the patient’s preferences. Delay between creation
and closure of the OWT ranged from 1 to 36 months (medi-
an, 6 months).
Intrathoracic muscular transposition was the procedure of
choice for closure of OWT and was carried out in 29
patients. If sufficient muscular bulk was available, an omen-
tal flap was used alone (n = 5) or in association with mus-
cular flaps (n = 2).
The Journal of Thoracic and
Cardiovascular Surgery
Volume 120, Number 2
Regnard et al 271
should take into account the infectious state, the char-
acteristics of the pleural space, and the presence of a
fistula.1,5
Adequate drainage is the first step in the treatment of
patients with postresection empyema.2,5-8 Closed tube
drainage is generally used in the acute phase, and open
drainage is carried out when clinical conditions are sta-
bilized.2,5-7 According to other authors, optimal
drainage of early postresection empyema is accom-
plished by reopening of the entire thoracotomy.8 On the
other hand, several controversies exist concerning the
management of a concurrent BPF, as well as the modal-
ities and the timing of definitive chest closure.2,5,7-9
In the present article we report our experience con-
cerning the treatment of postresection empyema by
using open window thoracostomy (OWT) followed by
intrathoracic muscular or omental transposition. Such
treatment was reserved for patients with persistent
empyema after the initial closed drainage.
Patients and methods
Patients. In the period from 1987-1998, 109 patients were
treated in our department for a postoperative empyema; this
empyema was associated to BPF in 97 cases.
During the same period, 3889 pulmonary resections were
performed in our department. OWT was performed in 46
patients after an initial closed tube drainage for a persistent
empyema.
Previous operations included pneumonectomy (n = 30),
bilobectomy (n = 5), lobectomy (n = 9), and wedge resection
(n = 2). Indications for pulmonary resection had been lung
cancer (n = 36) or benign diseases (n = 10). Among patients
with lung cancer, the final pathologic stage was I in 6, II in
19, and IIIA in 11 patients. Delay between resection and
empyema ranged from 5 days to 45 years (median, 32 days).
A BPF was present in 39 of 46 patients (Table I).
Pseudomonas aeruginosa, Staphylococcus aureus, and
Proteus mirabilis represented the microorganisms most fre-
quently isolated from empyema fluid specimens.
In all the patients, empyema was diagnosed on the basis of
clinical data, radiographic appearance, and laboratory exami-
nation of pleural fluid. All the patients underwent thoracic
computed tomographic scan. A fiberoptic bronchoscope was
used to search for an associated BPF.
Pleural drainage. In all patients, closed chest tube thora-
costomy was initially performed to drain the purulent collec-
tion and, in patients with BPF, to prevent aspiration by the
other lung. In the majority of cases, tube thoracostomy,
appropriate antibiotics, and supportive care allowed a gradual
improvement of clinical conditions.
In case of failure of closed drainage, OWT was planned to
achieve optimal pleural drainage and to allow hospital dis-
charge of patients. The delay between pulmonary resection
and OWT ranged from 7 days to 45 years (median, 67 days).
The site of OWT was selected on the basis of imaging stud-
Table I. Characteristics of subjects included in the
study according to the treatment modality
Definitive OWT plus
OWT flap transposition Overall
Lung cancer 8 28 36
Benign disease 2 8 10
BPF at presentation 8 31 39
Previous pneumonectomy 7 23 30
Previous bilobectomy 1 4 5
Previous lobectomy 2 7 9
Previous wedge resection — 2 2
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When a postpneumonectomy pleural space was judged too
large to be filled by the available flaps, a limited extrape-
riosteal thoracoplasty represented an intermediate step. It was
necessary in 9 patients and carried out through a posterolat-
eral incision, thus always preserving the pectoralis major
muscle, as well as the serratus anterior muscle.
To perform the muscular flap transposition, we used an
incision that included in its trajectory the previous thoracos-
tomy; skin flaps adequate for closure were obtained whenev-
er possible. The muscles to be used for transposition were
chosen by taking into account anatomic considerations, as
well as the entity of damage caused by previous operations.
Single or double muscular flaps were prepared (Table III);
extreme care was used to avoid injuries to the principal vas-
cular pedicles of the selected muscles. The flaps were passed
into the cavity through the thoracostomy. If a bronchial fistu-
la was still present, it was closed by suturing the muscle at its
edges. In most cases the muscular flap was sufficient to oblit-
erate the cavity entirely.
To perform the omentopexy, we created a large omental
pedicle by dividing the left or right gastroepiploic vessels and
detaching the gastroepiploic arch from the greater curvature
of the stomach. A pedicle based on the right or left gastroepi-
ploic vessels was used for transposition in the homolateral
hemithorax. The omentum was transposed to the thoracic
cavity through a substernal tunnel or an opening in the
diaphragm. Care was used to avoid compression of omental
vessels, as well as to prevent intestinal herniation. In the pres-
ence of a BPF, the omentum was sutured to its edges. In some
instances omental and muscular flaps were used together to
completely obliterate the pleural space (Table III).
Results
Outcome after OWT alone. OWT was definitive
and flap transposition never performed in 10 of 46
patients. The transposition was not carried out because
of patient death (one myocardial infarction and one
pulmonary embolism, occurring at 1 and 3 months,
respectively), concomitant major illness (n = 2),
locoregional (n = 2) or metastatic (n = 2) tumor recur-
rence, or patient choice (n = 1). In 1 case spontaneous
closure occurred. With the exception of the patient who
had a spontaneous closure, the survivors were managed
indefinitely on an outpatient clinic basis by local care.
Local control of the infection was satisfactory in all the
patients, and septicemia occurred in no one.
Spontaneous closure of BPF occurred in 5 patients.
Outcome after OWT and subsequent flap trans-
position. Thirty-three of 36 patients were alive 6
months after the completion of the treatment and avail-
able for assessment of treatment success. The causes of
the 3 deaths were recurrent empyema with septicemia
(treatment failure) in 2 patients and cancer progression
in 1 patient. All the deaths occurred more than 1 month
after the completion of the treatment and discharge
from the hospital. Neither flap necrosis nor other major
complications were observed. One wound infection
occurred, which was successfully managed by drainage
and antibiotics.
In 27 (75.0%) of 36 patients, the intrathoracic flap
transposition was successful; no infection recurred, and
definitive closure of thoracostomy was achieved.
Independent of the size of the residual pleural space at
the time of flap transposition, in 9 (25.0%) cases
empyema recurred, and reopening of the OWT was
necessary. Four of these patients were eventually suc-
cessfully treated by further intrathoracic muscular (1
patient) or omental (2 patients) transposition; in anoth-
er patient a thoracoplasty followed by omentopexy was
used with success. In the remaining 5 patients no fur-
ther attempt for closure was possible because of persis-
tent infection and the OWT was definitive. The overall
success rate was 86% (31/36; Table IV).
Among patients with BPF at the time of flap transpo-
sition (n = 14), the outcome was immediately favorable
in 10 (71.4%); among the 4 whose initial treatment
failed, 2 were successfully treated by further operations
(Table V).
Among patients without BPF, when flap transposi-
tion was performed (n = 22), a successful outcome was
observed in 17 (77.3%) patients; two of the patients
whose flap transposition was unsuccessful underwent a
successful reoperation (Table V).
Table II. Spontaneous closure of BPFs after OWT
No. of Spontaneous closure
initial BPFs of BPFs
Pneumonectomy (n = 30) 24 16
Bilobectomy (n = 5) 4 2
Lobectomy (n = 9) 9 3
Wedge resection (n = 2) 2 0
Table III. Intrathoracic flaps used
Single flap
Pectoralis major 15
Serratus anterior 1
Latissimus dorsi 6
Omentum 5
Double flap
Pectoralis major plus serratus anterior 4
Latissimus dorsi plus serratus anterior 2
Latissimus dorsi plus rhomboid 1
Latissimus dorsi plus omentum 1
Pectoralis major plus omentum 1
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Discussion
Adequate pleural drainage remains the cornerstone of
the initial treatment of empyema complicating pul-
monary resections. Tube thoracostomy allows empye-
ma drainage and prevents aspiration in the controlater-
al lung if a BPF is present.2,5,7 In our series, as well as
in the experience of several authors,2,5-7 closed chest
tube drainage represented the initial part of manage-
ment of postresection empyema and allowed for stabi-
lization of the patients’ clinical conditions. However,
closed drainage often fails to completely drain the cav-
ity with subsequent unsatisfactory control of the infec-
tion; in these cases open drainage is performed.2,5-7
Furthermore, open drainage allows for management of
patients on an outpatient clinic basis much more easily
than closed drainage. In our series, mean hospital stay
after OWT was 8 days.
In our study, OWT was carried out according to the
standard technique5; the entity of rib resection was as
limited as possible to ensure adequate drainage and
easy changes of dressings. In these severely ill patients
we preferred to limit the surgical trauma as much as
possible, and therefore no attempt was made to close a
BPF when present. This approach is probably responsi-
ble for the low incidence of complications observed in
the present series. Furthermore, similar to others’ expe-
rience,5 in 53.8% of cases, the BPF closed sponta-
neously after OWT, probably because of improvement
(or resolution) of the infective condition of the pleural
cavity. Other authors have advocated a more aggressive
management of early postresection empyema and BPF,
as well as different modalities of OWT closure.6,8,11
Pairolero and colleagues8 suggested immediate open
pleural drainage by reopening of the entire thoracoto-
my incision. In the presence of BPF they performed
restapling of long bronchial remnants (if present) or
complete reopening and resuture of short stumps.
Immediate muscular transposition is used to protect the
suture line or to cover the fistula if resuture is not pos-
sible.8 They suggested OWT closure with the second
stage of the Clagett procedure.10 By using this
approach, Pairolero and colleagues8 reported a suc-
cessful outcome in 26 (57.8%) of 45 patients; 6
(13.3%) operative deaths were also observed, and a
mean of 5 surgical procedures were necessary. It is
noteworthy that the second stage of the Clagett proce-
dure was followed by empyema recurrence in 5
(16.1%) of 31 evaluable patients.8 On the other hand,
several authors have used the 2-step Clagett procedure
(without flap transposition) in the treatment of postre-
section empyema. This technique is possible only in
the absence of BPF, and the results are very variable in
different authors’ experience. In the series of Stafford
and Clagett,12 sterilization of empyema and definitive
closure of the OWT were accomplished in 11 (61%) of
18 patients at the first attempt. Goldstraw2 reported
successful results in 17 (77.3%) of 22 patients in whom
the entire procedure could be completed, whereas in
the experience of Shamji and colleagues,7 in only 2 of
5 patients who underwent the second step of the proce-
dure was a permanent closure of the OWT achieved.
Gharagozloo and colleagues13 have recently reported
a surprisingly high success rate (100%) in patients with
early postpneumonectomy empyema associated with
BPF. They suggested a procedure based on emergency
tube drainage followed by thoracotomy, debridement
of necrotic tissue, bronchial stump resuture, and imme-
diate closure of the thoracotomy. Postoperative pleural
irrigation and obliteration of the space by antibiotic
solution constitute the final part of the treatment. The
authors speculated that in most patients in their popu-
lation a technical error in handling the bronchus at the
time of initial thoracotomy was probably responsible
for the occurrence of the BPF, and therefore they con-
sidered a technically satisfactory reclosure of the
bronchus of paramount importance in the management
of such patients. On the basis of these considerations,
we think that presently the approach suggested by
Gharagozloo and colleagues should be considered only
in a very selected subset of patients.
In our experience after OWT, intrathoracic muscular
or omental transposition was used to obliterate the
Table IV. Results of treatment procedures in patients treated by OWT followed by flap transposition, according to
the kind of initial operation
Initial success Initial failure New operation Success of new operation Overall success
Pneumonectomy (n = 23) 17 (73.9%) 6 (26.1%) 3 3 20 (86.9%)
Bilobectomy (n = 4) 2 (50%) 2 (50%) — — 2 (50%)
Lobectomy (n = 7) 6 (85.7%) 1 (14.3%) 1 1 7 (100%)
Wedge resection (n = 2) 2 (100%) 0 (0%) — — 2 (100%)
Overall (n = 36) 27 (75.0%) 9 (25.0%) 4 4 31 (86.1%)
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pleural space and, at the same time, to close a possibly
associated BPF. It has been reported that both omen-
tum14,15 and muscle5,16,17 flaps may play an important
role in infection control. Furthermore, both stimulate
neoangiogenesis of ischemic bronchial stumps.18-20 In
the present study a satisfactory success rate was also
observed among patients with persistent BPF at the
time of flap transposition.
The choice of muscles for transposition depends on
the location of the space to be filled, as well as on pre-
vious operations. Pectoralis major is the muscle of
choice for filling anterior cavities because of its bulk
and integrity after a posterolateral thoracotomy. It is a
general policy in our institution to respect the serratus
anterior in all thoracotomies, and therefore this muscle
is almost always available for transposition. The latis-
simus dorsi has also been used in several instances in
our series. If it had been preserved at the time of the ini-
tial operation—if an anterior thoracotomy or a muscle-
sparing lateral thoracotomy had been carried out—it
can be mobilized and transposed entirely. On the other
hand, it is generally believed that a previously divided
latissimus dorsi will survive in situ, but the entire mus-
cle will not survive as a proximally based muscle
flap.21 Furthermore, when a single muscle is not suffi-
cient, 2 or more muscles may be used, as in 8 patients
in our series.
In 9 patients in our series a limited extraperiosteal
thoracoplasty represented an intermediate step between
OWT and flap transposition. We did not carry out the
thoracoplasty and flap transposition at the same opera-
tive time to limit the surgical trauma in these weak
patients. In our opinion, thoracoplasty should be dis-
couraged as the definitive and only procedure for treat-
ment of postoperative empyema. When used alone,
extensive rib resection (full thoracoplasty) is generally
required, with a subsequent high operative mortali-
ty22,23 and significant physiologic changes negatively
affecting the function of the controlateral lung.23
Furthermore, the success rates reported are not com-
pletely satisfactory. Among 16 patients with BPF com-
plicating resection for lung cancer, Peppas and col-
leagues22 observed 4 hospital deaths and 2 treatment
failures. Young and Ungerleider24 reported an operative
mortality of 10% and 18% of survivors with persistent
empyema, BPF, or both.
Our results are in agreement with those reported in
previous studies in which similar techniques and tim-
ing were used in smaller series of patients.5,9 In partic-
ular, Cicero and colleagues9 reported good results in 2
of 2 patients with postresection empyema treated by
OWT followed by intrathoracic transposition of
myocutaneous flaps; on the other hand, Garcia-Yuste
and colleagues5 reported a successful outcome in 21 of
22 patients with tuberculous empyema and in 14 of 18
patients with postresection empyema by using OWT
followed by intrathoracic muscular transposition.
We believe that OWT followed by intrathoracic flap
transposition is a safe and effective technique in the
management of empyema complicating pulmonary
resections. Compared with the second step of the
Clagett procedure, in the absence of BPF at the time of
OWT closure, intrathoracic flap transposition provided
results similar to those reported by some authors2,12 but
remarkably better than those shown by others.7
Therefore, no definitive conclusion can be drawn. On
the other hand, in the presence of a persistent BPF, the
second step of the Clagett procedure is not feasible, and
flap transposition represents a very effective tool.
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